Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Neuronavigation Systems Market By Type, By Application, By End User, and Geography
Neuronavigation Systems Market size was valued at US$ 2,628.1 million in 2022, growing at a CAGR of 7.9% during the forecast period 2023 to 2029. neuronavigation systems market are innovative techniques that are developed for image-guided neurosurgery to aid in the accurate resection of brain tumors. Neuronavigation provides intraoperative orientation to the surgeons and helps in planning a precise surgical approach to the targeted lesion. The sensitive areas of the brain during surgery can be avoided by incorporating the functional data provided by functional MRI and magnetoencephalography (MEG) with neuronavigation. The basic principles of navigated surgery is to see the tip of a pointer in an image space. There must be a relationship between the device space and the image space that has to be established. Thus these systems help surgeons in constructing an accurate approach towards the targeted lesion by providing a proper outline of the surrounding neurovascular structures. The global market provides a detailed overview and which can be segmented by type, application, end-user, and region. By type, the market has been segmented into the optical system and electromagnetic system. By type, the optical system segment is expected to gain a significant growth rate over the forecasted period due to increasing demand for optical system devices for neurological problems.
Furthermore, continuous development in the optical system will surely enhance the demand in the healthcare sector. By application, the neuronavigation systems market has been segmented into neurosurgery, spinal surgery, maxillofacial surgery, and ENT surgery. By application, the ENT surgery segment held the largest revenue share of the neuronavigation systems market in past years and is expected to have the fastest growth rate over the forecasted period increasing neurological problems globally. Based on the end user, the segment has been segregated into hospitals, neurology centers, and others. The neurology centers segment is expected to lead the end-user segments owing to rising neurological disorders worldwide, which in turn requires neurological centers from a mass patient population. By region, North America holds the largest market share of the neuronavigation systems market and is expected to dominate the neuronavigation systems market due to the rise in the prevalence of neurological disorders and demand for technologically advanced neurological systems. Furthermore, government funding in this region for the improvement and development of surgical navigation systems and the increasing adoption of minimally invasive surgery is propelling the growth of the neuronavigation systems market in the region.
Study Period
2024-2030Base Year
2023CAGR
7.9%Largest Market
North AmericaFastest Growing Market
Europe
The key driver of neuronavigation systems market growth is increasing incidences of neurological disorders such as cancer, brain tumors, and stroke. Furthermore, the increasing demand for the neuronavigation systems market is fuelling its growth of the neuronavigation systems market. Moreover, other functionalities like planning of incision and craniotomy and determination of small subcortical lesions by neuronavigation systems are further boosting the demand for neuronavigation systems in the global market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2022 |
US$ 2,628.1 million |
Market CAGR |
7.9% |
By Test Type |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
The neuronavigation systems market vendors should focus on grasping business opportunities from the optical neuronavigation systems segment as it accounted for a significant market share in the base year.
The healthcare industry sector is the main driver of the neuronavigation systems market.
North America will register the highest growth rate among the other regions. Thus, the neuronavigation systems market in North America is expected to gather significant business opportunities for the vendors during the forecast period.
1.Executive Summary |
2.Global Neuronavigation Systems Market Introduction |
2.1.Global Neuronavigation Systems Market - Taxonomy |
2.2.Global Neuronavigation Systems Market - Definitions |
2.2.1.Type |
2.2.2.Application |
2.2.3.End User |
2.2.4.Route of Administration |
2.2.5.Region |
3.Global Neuronavigation Systems Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Neuronavigation Systems Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Neuronavigation Systems Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Optical System and Electromagnetic System |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
6.Global Neuronavigation Systems Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Neurosurgery |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Spinal Surgery |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Maxillofacial Surgery |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. ENT Surgery |
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Neuronavigation Systems Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Neurology Centers |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Neuronavigation Systems Market By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Injection |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Nasal Spray |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9.Global Neuronavigation Systems Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Neuronavigation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Optical System and Electromagnetic System |
10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Neurosurgery |
10.2.2.Spinal Surgery |
10.2.3.Maxillofacial Surgery |
10.2.4.ENT Surgery |
10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Neurology Centers |
10.3.3.Others |
10.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Injection |
10.4.2.Nasal Spray |
10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Neuronavigation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Optical System and Electromagnetic System |
11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Neurosurgery |
11.2.2.Spinal Surgery |
11.2.3.Maxillofacial Surgery |
11.2.4.ENT Surgery |
11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Neurology Centers |
11.3.3.Others |
11.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Injection |
11.4.2.Nasal Spray |
11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12.Asia Pacific (APAC) Neuronavigation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Optical System and Electromagnetic System |
12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Neurosurgery |
12.2.2.Spinal Surgery |
12.2.3.Maxillofacial Surgery |
12.2.4.ENT Surgery |
12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Neurology Centers |
12.3.3.Others |
12.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Injection |
12.4.2.Nasal Spray |
12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Neuronavigation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Optical System and Electromagnetic System |
13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Neurosurgery |
13.2.2.Spinal Surgery |
13.2.3.Maxillofacial Surgery |
13.2.4.ENT Surgery |
13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Neurology Centers |
13.3.3.Others |
13.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Injection |
13.4.2.Nasal Spray |
13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Neuronavigation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Optical System and Electromagnetic System |
14.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Neurosurgery |
14.2.2.Spinal Surgery |
14.2.3.Maxillofacial Surgery |
14.2.4.ENT Surgery |
14.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Hospitals |
14.3.2.Neurology Centers |
14.3.3.Others |
14.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Injection |
14.4.2.Nasal Spray |
14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Heal Force (China) |
15.2.2.Scopis (Germany) |
15.2.3.Atracsys (Switzerland) |
15.2.4.NDIgital (Canada) |
15.2.5.Surgical Theater (USA) |
15.2.6.Micromar (Brazil) |
15.2.7.henzhen Anke High-Tech (China) |
15.2.8.Synaptive Medical (Canada) |
15.2.9.ClaroNav (Canada) |
15.2.10.Parseh Intelligent Surgical System (Iran) |
15.2.11.Stryker Acute Care (USA) |
15.2.12.Brainlab (Germany) |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players